

Cordlife Sciences India Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
- Paid Up Capital ₹ 45.35 Cr
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth -0.48%
- Profit Growth -318.58%
- Ebitda -68.22%
- Net Worth -18.84%
- Total Assets 8.49%
About Cordlife Sciences India
Cordlife Sciences India Pvt Ltd (CSIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 December 2005 and has a history of 19 years and four months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 45.35 Cr.
The company has closed loans amounting to ₹3.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cordlife Sciences India Pvt Ltd India is Amit Srivastava as CEO. Prosanto Chowdhury and Vishal Kanodia serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85196WB2005PTC106719
- Company No.
106719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2005
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
What products or services does Cordlife Sciences India Pvt Ltd offer?
Cordlife Sciences India Pvt Ltd offers a wide range of products and services, including .
Who are the key members and board of directors at Cordlife Sciences India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amit Srivastava | CEO | 01-Oct-2022 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prosanto Chowdhury ![]() | Director | 30-Dec-2020 | Current |
Vishal Kanodia | Director | 17-Oct-2024 | Current |
Financial Performance of Cordlife Sciences India.
Cordlife Sciences India Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.48% decrease. The company also saw a substantial fall in profitability, with a 318.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.84%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cordlife Sciences India?
In 2023, Cordlife Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Genoclimics Private Limited
Prosanto Chowdhury is a mutual person
Charges (Loans)
₹0
₹3.00 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 3.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Feb 2018 | Citi Bank N.A. | ₹3.00 Cr | Satisfied |
How Many Employees Work at Cordlife Sciences India?
Cordlife Sciences India has a workforce of 349 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cordlife Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cordlife Sciences India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Cordlife Sciences India
Recent activity within the organization
- Director Appointment
Vishal Kanodia was appointed as a Director was appointed as a Director on 17 Oct 2024 & has been associated with this company since 6 months 28 days .
- Annual General Meeting
Cordlife Sciences India Pvt Ltd last Annual general meeting of members was held on 13 Sep 2024 as per latest MCA records.
- Balance Sheet
Cordlife Sciences India Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
- Director Appointment
Amit Prakash Srivastava was appointed as a Ceo was appointed as a Ceo on 01 Oct 2022 & has been associated with this company since 2 years 7 months .
- Director Appointment
Prosanto Kumar Chowdhury was appointed as a Director was appointed as a Director on 30 Dec 2020 & has been associated with this company since 4 years 4 months .
- Charges
A charge registered on 23 Feb 2018 via Charge ID 100162069 with Citi Bank N.A. was fully satisfied on 21 Nov 2018.
Recent News, Updates & Announcement
- Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India.
/PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing,....
- Cord Blood Banking Services Market - Forecasts from 2018 to 2023: Key Players are CBR Systems, Inc., Cordlife, Cryo-Cell, Cryo-Save AG, LifeCell, and Stemcyte.
/PRNewswire/ -- The "Cord Blood Banking Services Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. Global cord....
Frequently asked questions
What is the Incorporation or founding date of Cordlife Sciences India Pvt Ltd?
Cordlife Sciences India Pvt Ltd was incorporated on 16 Dec 2005.
What is authorized share capital and paid-up capital of Cordlife Sciences India Pvt Ltd?
The authorized share capital of Cordlife Sciences India Pvt Ltd is ₹ 65.00 Cr and paid-up capital is ₹ 45.35 Cr.
Who are the current board members & directors of Cordlife Sciences India Pvt Ltd?
Currently 3 directors are associated with Cordlife Sciences India Pvt Ltd.
- Prosanto Kumar Chowdhury
- Vishal Kanodia
- Amit Prakash Srivastava
What is the registered address of Cordlife Sciences India Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Cordlife Sciences India Pvt Ltd is P.L. Deuty Road India, Bishnupur, West Bengal, 743503.
What is the corporate identification number (CIN) and company number of Cordlife Sciences India Pvt Ltd?
The corporate identification number (CIN) of Cordlife Sciences India Pvt Ltd is U85196WB2005PTC106719 and the company number is 106719 as per Ministry of Corporate Affairs (MCA).
What is the official website of Cordlife Sciences India Pvt Ltd?
The Official website of Cordlife Sciences India Pvt Ltd is https://www.cordlifeindia.com
What has been the recent revenue trend for Cordlife Sciences India Pvt Ltd?
According to the financial reports for the fiscal year 2023, the revenue trend for Cordlife Sciences India Pvt Ltd has fallen by -0.48%.
How many employees does Cordlife Sciences India Pvt Ltd currently have?
As Per 2023 financial reports, 349 employees are currently employed by Cordlife Sciences India Pvt Ltd.
What change has been observed in the net worth of Cordlife Sciences India Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Cordlife Sciences India Pvt Ltd has experienced an downturn of -18.84%.
When was the last Balance Sheet of Cordlife Sciences India Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Cordlife Sciences India Pvt Ltd was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
MC
Meghnath ChowdhuryManaging DirectorDR
Deep RoychowdhuryDirectorRR
Rupnath RoychowdhuryDirectorFB
Fang BoonDirectorSK
Susan KhengDirectorJY
Jeremy YeeDirectorML
Moh LeeDirectorAM
Arijit MookerjeeDirector
Similar Companies Based on Diagnostic Centers & Pathology Labs
- Ortho Clinical Diagnostics India Private Limited Mumbai, Maharashtra, India
- Carestream Health India Private Limited Mumbai, Maharashtra, India
- Thyrocare Technologies Limited Thane, Maharashtra, India
- Bio-Rad Laboratories (India) Private Limited Gurugram, Haryana, India
- Fortis Healthcare Limited Rupnagar, Punjab, India
- Bpl Medical Technologies Private Limited Bangaluru, Karnataka, India
- Metropolis Healthcare Limited Mumbai, Maharashtra, India
- Agilus Diagnostics Limited Rupnagar, Punjab, India